Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial

Joint Authors

Wang, Huaping
Graumlich, James F.
Madison, Anna
Wolf, Michael S.
Kaiser, Darren
Morrow, Daniel G.
Dahal, Kumud

Source

Journal of Diabetes Research

Issue

Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-16, 16 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2016-09-06

Country of Publication

Egypt

No. of Pages

16

Main Subjects

Diseases
Medicine

Abstract EN

Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain.

Objective.

Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning tool (Medtable™) implemented via an electronic medical record to improve patients’ medication knowledge, adherence, and glycemic control compared to usual care.

Design.

A multicenter, randomized controlled trial in outpatient primary care clinics.

674 patients received either the Medtable tool or usual care and were followed up for up to 12 months.

Results.

Patients who received Medtable had greater knowledge about indications for medications in their regimens and were more satisfied with the information about their medications.

Patients’ knowledge of drug indication improved with Medtable regardless of their literacy status.

However, Medtable did not improve patients’ demonstrated medication use, regimen adherence, or glycemic control (HbA1c).

Conclusion.

The Medtable tool supported provider/patient collaboration related to medication use, as reflected in patient satisfaction with communication, but had limited impact on patient medication knowledge, adherence, and HbA1c outcomes.

This trial is registered with ClinicalTrials.gov NCT01296633.

American Psychological Association (APA)

Graumlich, James F.& Wang, Huaping& Madison, Anna& Wolf, Michael S.& Kaiser, Darren& Dahal, Kumud…[et al.]. 2016. Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial. Journal of Diabetes Research،Vol. 2016, no. 2016, pp.1-16.
https://search.emarefa.net/detail/BIM-1108002

Modern Language Association (MLA)

Graumlich, James F.…[et al.]. Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial. Journal of Diabetes Research No. 2016 (2016), pp.1-16.
https://search.emarefa.net/detail/BIM-1108002

American Medical Association (AMA)

Graumlich, James F.& Wang, Huaping& Madison, Anna& Wolf, Michael S.& Kaiser, Darren& Dahal, Kumud…[et al.]. Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial. Journal of Diabetes Research. 2016. Vol. 2016, no. 2016, pp.1-16.
https://search.emarefa.net/detail/BIM-1108002

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1108002